Anlon Healthcare — Quarterly Results & Earnings

₹111.38

-0.87%

Profit Growth YoY259.85%Latest quarter

Sales Growth YoY115.97%Latest quarter

Sales CAGR 5YN/A5 year compound

Profit CAGR 5YN/A5 year compound

📋

Quarterly Performance

YoY Profit Growth+259.85%

🔥 Exceptional growth

YoY Sales Growth+115.97%

🔥 Exceptional growth

OPM 5Y Average

Operating profit margin

16.42%

EPS Growth 5Y

N/A

Interest Coverage

Higher = safer debt servicing

7.64

ROE

40.45%

ROCE

24.83%

💡

Growth Analysis

Anlon Healthcare reported YoY profit growth of 259.85% and revenue growth of 115.97% in the latest quarter. Double-digit profit growth above 20% is exceptional — indicates strong business momentum. Over 5 years, sales compounded at N/A and profits at N/A annually. Consistent growth over 4-8 quarters is more meaningful than any single quarter. Educational data only.

More on Anlon Healthcare

Overview Financials PE History Shareholding Quarterly Balance Sheet P&L Cash Flow Pharmaceuticals Stocks Screener

Data from NSE/BSE public filings. Educational purposes only. Bull Run is not SEBI-registered. Not investment advice.